LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 178 filers reported holding LEGEND BIOTECH CORP in Q2 2024. The put-call ratio across all filers is 1.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $508,861 | -17.1% | 11,489,275 | +4.9% | 0.06% | -18.7% |
| Q1 2024 | $614,137 | -5.6% | 10,949,120 | +1.3% | 0.08% | -13.8% |
| Q4 2023 | $650,332 | -0.1% | 10,808,216 | +11.5% | 0.09% | -8.4% |
| Q3 2023 | $651,105 | +4.4% | 9,693,368 | +7.3% | 0.10% | +9.2% |
| Q2 2023 | $623,434 | +1083.8% | 9,031,324 | +726.9% | 0.09% | +987.5% |
| Q1 2023 | $52,665 | +61.2% | 1,092,149 | +66.9% | 0.01% | +60.0% |
| Q4 2022 | $32,674 | -99.9% | 654,519 | -0.2% | 0.01% | +25.0% |
| Q3 2022 | $26,757,000 | -14.2% | 655,798 | +15.6% | 0.00% | 0.0% |
| Q2 2022 | $31,194,000 | +765.3% | 567,155 | +356.5% | 0.00% | – |
| Q1 2021 | $3,605,000 | -77.9% | 124,229 | -78.6% | 0.00% | -100.0% |
| Q4 2020 | $16,327,000 | -9.7% | 579,777 | -1.0% | 0.00% | 0.0% |
| Q3 2020 | $18,075,000 | -50.0% | 585,508 | -31.0% | 0.00% | -60.0% |
| Q2 2020 | $36,134,000 | – | 849,017 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 560,506 | $26,125,000 | 18.14% |
| JOHNSON & JOHNSON | 1,629,173 | $75,936,000 | 8.64% |
| HHLR ADVISORS, LTD. | 11,804,925 | $550,228,000 | 8.50% |
| Paradigm Biocapital Advisors LP | 385,967 | $17,990,000 | 5.14% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,004,742 | $46,831,000 | 4.89% |
| Yong Rong (HK) Asset Management Ltd | 130,000 | $6,060,000 | 4.79% |
| Old Well Partners, LLC | 79,700 | $3,715,000 | 2.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $9,322,000 | 1.88% |
| Tri Locum Partners LP | 89,840 | $4,187,000 | 1.65% |
| INDUS CAPITAL PARTNERS, LLC | 123,054 | $5,736,000 | 1.36% |